Savvy Updates 11/13/23: Diamyd Medical/DiaUnion Trial for Precision Medicine, Cost of Diabetes Skyrockets, OptumRx Moves Insulin to Preferred Status, FDA Warns Against SugarMD Supplement, Human Insulin Storage, Interview with Dr. Mike Natter, Broccoli Benefits, Food for Thought with Gina Pillini

Savvy Updates 11/13/23: Diamyd Medical/DiaUnion Trial for Precision Medicine, Cost of Diabetes Skyrockets, OptumRx Moves Insulin to Preferred Status, FDA Warns Against SugarMD Supplement, Human Insulin Storage, Interview with Dr. Mike Natter, Broccoli Benefits, Food for Thought with Gina Pillini

Nov 13, 2023 | A Little Humor, Diabetes Business, Featured, Foods, Podcasts, Research News, Technology Updates

Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial posted on PRNewsWire.com, 7 November 2023. Diamyd Medical has entered into a collaboration agreement with DiaUnion, a center of excellence in type 1 diabetes, to...
Savvy Updates, 10/30/23: Omnipod 5 Cleared for iPhone, Tandem Mobi Listed as One of Top Inventions of 2023, Eye Implants Treats T1D, Dexcom Stock Soars, ExpressScripts Sues for Pricing Fixing, Diagnose Diabetes by Phone/Voice, Halloween & T1D

Savvy Updates, 10/30/23: Omnipod 5 Cleared for iPhone, Tandem Mobi Listed as One of Top Inventions of 2023, Eye Implants Treats T1D, Dexcom Stock Soars, ExpressScripts Sues for Pricing Fixing, Diagnose Diabetes by Phone/Voice, Halloween & T1D

Oct 30, 2023 | Diabetes Business, Featured, Foods, Research News, Technology Updates

Insulet celebrates Apple season with FDA clearance for Omnipod 5 iPhone app by Andrea Park for FierceBioTech.com, 23 October 2023. Insulet has earned FDA clearance for the iPhone version of an app allowing users to control their Omnipod 5 insulin pumps from their own...
Savvy Updates 10/16/23: Insulet Wins Prelim Injunction v. EOFlow, T1D & Emotional Distress, Best Buy Sells CGMs, Treating CKD in T1D, Vertex New Data, Biomea Fusion’s Cell Therapy Application Cleared, 6th Basic Flavor – Umami, NPs Sue for “Dr.” Title, Avg Body Temp Lower Than 98.6

Savvy Updates 10/16/23: Insulet Wins Prelim Injunction v. EOFlow, T1D & Emotional Distress, Best Buy Sells CGMs, Treating CKD in T1D, Vertex New Data, Biomea Fusion’s Cell Therapy Application Cleared, 6th Basic Flavor – Umami, NPs Sue for “Dr.” Title, Avg Body Temp Lower Than 98.6

Oct 16, 2023 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Insulet wins preliminary injunction against EOFlow in patent suit by Susan Kelly for MedTechDive.com, 9 October 2023.  A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump. The U.S. District Court for...
Savvy Updates 10/9/23: Insulin Resistance, Ozempic Warning, Exec Changes in D Companies, HbA1c Cutoffs Need To Be Lower in Premenopausal Women, Hybrid Closed Loop System Safe for T1D in Pregnancy, Mfr Co-Pay Card Accumulators Overturned

Savvy Updates 10/9/23: Insulin Resistance, Ozempic Warning, Exec Changes in D Companies, HbA1c Cutoffs Need To Be Lower in Premenopausal Women, Hybrid Closed Loop System Safe for T1D in Pregnancy, Mfr Co-Pay Card Accumulators Overturned

Oct 9, 2023 | Diabetes Business, Featured, Research News, Technology Updates

What Is Insulin Resistance and How Do You Know if You Have It? by Knvul Sheikh for NYTimes.com, 3 October 2023. Insulin is a hormone secreted by the pancreas that is crucial for converting food into energy, or storing that energy for later. When your blood...
Savvy Updates, 10/2/23: Senseonics Completes 365-Day Study, SiBionics CGM & GiveAway, Abvance’s Coformulation of Insulin & Glucagon, Period Cravings & Insulin Sensitivies, Ozempic Reduces Insulin Needs in T1Ds, CVS Caremark Sued By Independent Pharmacy for Antitrust Violations

Savvy Updates, 10/2/23: Senseonics Completes 365-Day Study, SiBionics CGM & GiveAway, Abvance’s Coformulation of Insulin & Glucagon, Period Cravings & Insulin Sensitivies, Ozempic Reduces Insulin Needs in T1Ds, CVS Caremark Sued By Independent Pharmacy for Antitrust Violations

Oct 2, 2023 | Diabetes Business, Featured, Foods, LOOPing, Research News, Technology Updates

Senseonics completes 365-day CGM study cohort by Sean Whooley for DrugDeliveryBusiness.com, 26 September 2023. Senseonics announced that it completed its ENHANCE pivotal clinical study adult cohort for its 365-day Eversense CGM.  The study evaluates the year-long...
Skip to content